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httpcense.Abstract Introduction: One lung ventilation (OLV) has become a standard procedure for many
interventions in thoracic surgery with a need for deﬂation of the lung to facilitate the surgical pro-
cedure. Mechanical ventilation can induce a proinﬂammatory reaction in the non-deﬂated venti-
lated lung. However only limited data exist on inﬂammatory alterations in the temporarily
deﬂated, non-ventilated lung in patients undergoing thoracic surgery.
Aim of the work: The aim of this work is to compare between the effects of propofol and sevo-
ﬂurane as regards: the systemic inﬂammatory response, the pulmonary inﬂammatory response, C-
reactive protein, leucocyte count, and recovery status, in patients undergoing thoracic surgery using
OLV technique.
Patients and methods: This study include 40 adult patients, who were randomly classiﬁed into
two groups: group (I) 20 patients received total intravenous anesthesia with propofol. Group (II)
20 patients received inhalational anesthesia with sevoﬂurane. Every patient was subjected to a care-
ful pre-anaesthetic assessment, anaesthesia, bronchoalveolar lavage (BAL) analysis for human
inﬂammatory mediators (IL-6 and TNF-a), serum analysis for systemic inﬂammatory mediators
(IL-6 and TNF-a) (Both were measured before OLV and 15 min after OLV ended and resumption
of two lung ventilation (TLV) at the end of surgery, and C-reactive protein and leukocyte count in
blood (before OLV, 15 min after OLV ended and resumption of (TLV) at the end of surgery and on
the 2nd postoperative day).23926049.
(A.A. AlGanady).
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732 S.A. Hammouda et al.Results: According to IL-6 andTNF-a, there was no statistically signiﬁcant difference between the
two groups before OLV, however they were signiﬁcantly increased in both groups in serum and BAL
after OLV in relation to before OLV with signiﬁcant increase in group I relative to group II. A signif-
icant correlation was present between increased level of IL-6 and TNF-a in BAL and their levels in
serum after OLV in the group II but this correlation was not present in the group I. Also no signiﬁcant
correlation between duration of OLV and inﬂammatory mediators (IL-6 and TNF-a) in serum and
BAL in both groups. As regarding to CRP, there was no statistically signiﬁcant difference between
the two groups before OLV. After OLV and on the 2nd postoperative day the level of CRP increased
signiﬁcantly in both groups with signiﬁcant increase in group I relative group II. According to WBC
count there was no statistically signiﬁcant difference between the two groups as regards the level of
WBC before OLV. After OLV the level of WBC increased signiﬁcantly in group I only. On the 2nd
postoperative day the level of WBC increased signiﬁcantly in both groups with signiﬁcant increase
in group I relative to group II. Also no signiﬁcant correlation between duration of OLV with the
increased levels of CRP and WBC count in both groups.
Conclusion: Propofol increased pulmonary and systemic cytokine release more than sevoﬂurane
during OLV. Propofol has increased CRP level andWBC count more than sevoﬂurane during OLV.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.Open access under CC BY-NC-ND license.Introduction
One lung ventilation is a technique that allows isolation of the
individual lungs under anesthesia. Safe implementation of this
technique requires an understanding of specialized airway
equipment’s, and of the physiological changes that occur during
the procedure [1].
Selective intubation was described for the ﬁrst time in 1932
by Gale and Waters, who used a single-light tube that was in-
serted into the right or left main stem bronchus. Since then,
alternative methods have been proposed in order to make this
technique safer and facilitate its practice [2].
Themain indications for OLV include, isolation of the lungs,
improve surgical access, greater control over ventilation as in
unilateral bronchopleural ﬁstula, unilateral BAL, and differen-
tial lung ventilation in ICU.OLVcould be established by double
lumen endotracheal tubes, bronchial blockers, and endo bron-
chial intubation.
During TLV in the lateral position, the mean blood ﬂow to
the nondependent lung is assumed to be 40% of cardiac output
(COP), whereas 60% of COP goes to the dependent lung. Nor-
mally, venous admixture (shunt) in the lateral position is 10%of
COP and is equally divided as 5% in each lung. Therefore, the
average percentage of COP participating in gas exchange is
35% in the nondependent lung and 55% in the dependent lung
[3].lung ventilation versus one-lung ventilation (One lung ventilation creates an obligatory right-to-left
trans pulmonary shunt through the nonventilated, nondepen-
dent lung because the V/Q ratio of that lung is zero. In theory,
an additional 35% should be added to the total shunt during
OLV. However, assuming active hypoxic pulmonary vasocon-
striction (HPV), blood ﬂow to the nondependent hypoxic lung
will be decreased by 50% and therefore is (35/2) = 17.5%. To
this, 5% must be added, which is the obligatory shunt through
the nondependent lung. The shunt through the nondependent
lung is therefore 22.5%. Together with the 5% shunt in the
dependent lung, total shunt during OLV is 22.5%+ 5%
= 27.5%. Because 72.5% of the perfusion is directed to the
dependent lung during OLV, the matching of ventilation in
this lung is important for adequate gas exchange. The depen-
dent lung is no longer on the steep (compliant) portion of
the volume-pressure curve [3].
Mechanical TLV produces homogeneously distributed
alveolar damage itself and generates an inﬂammatory response
in the alveoli even in healthy lungs. The resulting ventilation-
induced lung injury is characterized by dysfunction of the sur-
factant system, alveolar and interstitial edema, leukocyte
recruitment, cytokine production and neutrophil-dependent
tissue destruction [4].
One lung ventilation as an established procedure during
thoracic surgery may be injurious in terms of increasedOLV).(3) 
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distension, increased cyclic recruitment of alveolar units, com-
pression of alveolar vessels and increased pulmonary alveolar
resistance. This may result in ventilator induced lung injury
with pro inﬂammatory cytokine production [5].
After acute injury or during infections, TNF-a is among the
earliest and most potent mediators of subsequent host re-
sponses. The primary sources of TNF-a synthesis include
monocytes, macrophages and T cells [6].
TNF-a is also a major inducer of muscle catabolism and ca-
chexia during stress by shunting available amino acids to the
hepatic circulation as fuel substrates. Other functions of
TNF-a include activation of coagulation, promoting the
expression or release of adhesion molecules, prostaglandin
E2, PAF, glucocorticoids and eicosanoids [7].
Interleukin 6 is also a primary effector in the production of
other acute-phase proteins, including antiproteinases and
ﬁbrinogen, which are involved in nonspeciﬁc and speciﬁc
immunity as inﬂammatory mediators, scavengers and protease
inhibitors. Accordingly, increased levels of IL-6 in surgical
trauma are associated with marked elevations of levels of C-
reactive proteins and neutrophil elastase [8].
IL-6 may inﬂuence polymorphonuclear leukocyte (PMNL)
mediated inﬂammation via its role in stimulating the prolifer-
ation of PMNL progenitors in the bone marrow [9]. Other
cytokines may have less important roles in postoperative im-
mune dysfunction.
CRP is a phylogenetically highly conserved plasma protein,
with homologs in vertebrates and many invertebrates, that
participates in the systemic response to inﬂammation. Its plas-
ma concentration increases during inﬂammatory states, a char-
acteristic that has long been employed for clinical purposes the
measurement of cytokines in BAL ﬂuid are indicators of
inﬂammatory activity in the distal airways [10]. Cytokines
can be quantiﬁed using immunoassays such as the enzyme-
linked immunosorbent assay (ELISA), which measure total
antigenic material, or using bioassays as a measure of function.
Immunoassays, give an indication of the total cytokine burden,
while bioassays indicate whether the cytokine retains activity
and whether natural cytokine inhibitors are present [11].
Aim of the work
The aim of this work was to compare between the effects of
propofol and sevoﬂurane regarding:
(1) The systemic inﬂammatory response (IL-6 and TNF-a)
through serum analysis.
(2) The pulmonary inﬂammatory response (IL-6 and TNF-
a) through BAL analysis.
(3) C-reactive protein and leukocyte count in serum.
(4) Recovery status.
All of these parameters were measured in patients sched-
uled for open thoracic surgeries using OLV.
Patients
This study was carried out on 40 adult patients, of both sexes,
admitted to Alexandria Main University Hospital, Depart-
ment of Cardiothoracic Surgery. Patients were scheduled forelective lung resection surgery through thoracotomy. Patients
were randomly classiﬁed into two equal groups twenty patients
each;
 Group I: Patients received total intravenous anaesthesia
with propofol as maintenance.
 Group II: Patients received inhalational anaesthesia with
sevoﬂurane as maintenance.
Exclusion criteria
(1) Acute pulmonary or extra pulmonary infections.
(2) Severe chronic obstructive pulmonary diseases, and his-
tory of recurrent pneumothoraces.
(3) Pneumonectomy and lung volume reduction surgery.
(4) Contraindications for epidural catheter insertion.
(5) Patients on chemotherapy, radiotherapy, immunosup-
pressant drugs or corticosteroids.
(6) History of allergy to local anaesthetic drugs.
(7) Trauma patients.
Methods and measurements
After approval of the Ethical Committee of the Faculty of
Medicine and an informed written consent was obtained from
each patient, a prospective randomized blind study was
performed.
Every patient was subjected to a careful pre-anesthetics
assessment including
(1) History taking as regards current medical illnesses and
drug therapy.
(2) Thorough clinical examination and routine laboratory
investigations.
(3) Pulmonary function tests.
Anaesthesia
Premedication: midazolam (7.5 mg) was given orally 60 min
before induction of anaesthesia.
Before intubation a thoracic epidural catheter was in-
serted at T4–T5 to T7–T8 for intraoperative and postopera-
tive analgesia.The position of the catheter tip was veriﬁed by
a test dose of 3 ml lignocaine 2% with adrenaline (5 lg ml).
Induction of anaesthesia was initiated with fentanyl (2 lg/
kg) and propofol till loss of verbal contact; tracheal intubation
was facilitated with cisatracurium (0.15 mg/kg) in both groups.
According to the studied group, maintenance of anaesthe-
sia was performed by
(1) Propofol infusion technique (50–200 lg/kg/minute) in
Group I. Started with 150–200 lg/kg/minute, after
30 min 100-150 lg/kg/minute and after 2 h 50–100 lg/
kg/minute.
(2) Sevoﬂurane (1-2 MAC) in Group II.
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infusion of 0.125% bupivacaine (5–8 ml/h) and fentanyl (1 lg/
ml of 0.125% bupivacaine) through epidural catheter using
syringe pump.
In both groups, a double-lumen endobronchial tube was in-
serted and the correct position was conﬁrmed by auscultation
and ﬂexible ﬁbroptic bronchoscopy (FOB). Volume-controlled
ventilation was used for both TLV and OLV. For TLV, tidal
volumes of (8–10 ml/kg) and a respiratory frequency of 10–
12/minute were chosen to maintain arterial carbon dioxide
normocapnic. For OLV, tidal volumes of 6–7 ml/kg with a
respiratory frequency of 12–16/min were used with FiO2 of 1.0.
After completion of surgery, reventilation of the previously
non ventilated lung was performed, and after discontinuation
of anaesthetic agents,, neuromuscular blockade was reversed
using neostigmine and atropine sulphate, patients were extu-
bated and taken to the intensive care unit for postanaesthetic
care.
Postoperative pain was managed as intraoperatively. Anal-
gesia was maintained for 2–4 days until the chest tubes were
removed.
In all patients, BAL was performed by FOB under sterile
conditions. The tip of the bronchoscope was wedged into a
subsegmental bronchus of the nondependant lung. Different
segments were randomly chosen for repetition of BAL. Lavage
was performed by sequential instillation and gentle aspiration
of isotonic sodium chloride solution (10-ml portions, with a to-
tal of 50 ml) then the lavaged ﬂuid was aspirated. The ﬁrst
BAL was performed before OLV on the operated side (T1),
and the second BAL was performed 15 min after reexpansion
and reventilation of the same lung at the end of surgery (T2).
At the same time points, T1 and T2, 10 ml peripheral blood
were collected for laboratory investigations.
Both BAL and blood samples were centrifuged. Cell pellets
from centrifuged BAL and blood samples were assessed for
human inﬂammatory mediators (interleukin 6 [IL-6] and tu-
mor necrosis factor a [TNF-a].
Monitoring
A Using multichannel monitor, patients were continuously
monitored for:
(1) Non invasive arterial blood pressure.
(2) Lead II electrocardiography.
(3) Heart rate.
(4) Arterial oxygen saturation.
(5) End tidal carbon dioxide tension.
B Ventilatory monitoring (mean airway pressure and peak
airway pressure).
Measurements
The following parameters were measured for all patients in
both groups:
(1) Demographic data, age (yrs), sex, height (cm) and
weight (kgs).
(2) Type of surgery (lobectomy, segmentectomy and lung
biopsy).
(3) Haemodynamic parameters including:
A Heart rate (beats/minute).B Mean arterial blood pressure (mmHg).
(4) Parameters were recorded at the following times; base
line value (before induction), just after intubation, with
skin incision, every 15 min during surgery, before OLV
and 15 min after OLV ended and resumption of TLV.
(5) Arterial blood gases analysis (before OLV and 15 min
after OLV ended and resumption of TLV.
(6) BAL analysis for human inﬂammatory mediators (IL-6
and TNF-a) and serum analysis for systemic inﬂamma-
tory mediators (IL-6 and TNF-a). Both were measured
before OLV and 15 min after OLV ended and resump-
tion of TLV at the end of surgery.
(7) C-reactive protein and leukocyte count in blood (before
OLV, 15 min after OLV ended and resumption of TLV
at the end of surgery and on the 2nd postoperative day).
(8) Duration of anesthesia, surgery and OLV (minutes).
(9) Recovery status (modiﬁed Steward Score) [12]. A score
for consciousness, airway and motor activity. The score
was recorded on admission to the recovery room and
15 min after that.
A Consciousness: awake (2), responding to stimuli (1) and not
responding (0).
B Airway: coughing on command or crying (2), maintaining
good airway (1), and airway requires maintenance (0).
C Motor activity: moving limb purposefully (2), non purpose-
ful movements (1) and not moving (0).
A total score of six for a fully recovered patient. A score of
zero would be assigned to an unresponsive, immobile patient
whose airway requires maintenance.
Statistical analysis of the data
Data were analyzed using SPSS software package version 18.0
(SPSS, Chicago, IL, USA). Quantitative data was expressed
using Range, mean and standard deviation while Qualitative
data was expressed in frequency and percent. Qualitative data
was analyzed using Chi-square test also exact tests such Fisher
exact and Monte Carlo was applied to compare the two
groups. While, McNemar–Bowker was used to analyze the sig-
niﬁcance between the different stages. Quantitative data was
analyzed using Mann Whitney test to compare between two
groups. Wilcoxon Signed Rank test was used to compare be-
tween the different periods.
Results
Patients were randomly classiﬁed into; Group I: 20 Patients re-
ceived total intravenous anaesthesia with propofol as mainte-
nance.Group II: 20 Patients received inhalational anaesthesia
with sevoﬂurane as maintenance.
Demographic data
The age of patients of group I ranged from 34 to 69 with a
mean of 52.9 ± 9.8 years and ranged from 29 to 71 with a
mean of 54.5 ± 12.4 years in group II with no signiﬁcant dif-
ference between both groups. (P= 0.643). 30 Patients (65%)
of group I were males and 7 (35%) were females. In group
II, there were 12 males (60%) and 8 females (40%) with no
Table 1 Demographic data of the two studied groups.
Ser Age (yrs) Sex Height (cm) Weight (kg)
Group I Group II Group I Group II Group I Group II Group I Group II
1 45 54 Male Male 160 187 70 74
2 56 48 Female Male 165 167 71 90
3 44 62 Male Female 188 170 75 78
4 55 58 Female Male 172 180 56 105
5 66 55 Female Male 168 179 82 91
6 62 60 Male Female 185 169 69 71
7 35 65 Male Male 177 168 101 93
8 44 29 Female Male 172 176 67 75
9 49 68 Male Male 166 186 110 97
10 58 35 Male Female 188 163 79 57
11 49 58 Male Male 191 184 88 86
12 55 66 Female Female 181 171 65 72
13 65 61 Female Male 166 185 54 71
14 69 71 Male Male 179 193 85 109
15 53 41 Male Female 182 170 73 73
16 60 30 Male Female 169 162 82 57
17 34 60 Female Male 168 189 59 108
18 51 48 Female Female 170 174 66 76
19 62 66 Male Female 172 166 86 61
20 45 55 Female Male 161 177 54 98
Min 34.0 29.0 M 13 (65%) M 12 (60%) 160.0 162.0 54.0 57.0
Max 69.0 71.0 F 7 (35%) F 8 (40%) 191.0 193.0 110.0 109.0
Mean 52.9 54.5 X2 0.10 174.0 175.8 74.6 82.1
±SD 9.8 12.4 9.3 9.2 14.9 16.2
P 0.643 0.749 0.542 0.136
p is signiﬁcant if 6 0.05.
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Figure 1 Comparison between both groups as regards type of
operation.
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height of patients of group I ranged from 160 to 191 cm with
a mean of 174 ± 9.3 cm, and ranged from 162 to 193 cm with
a mean of 175.8 ± 9.2 cm in group II with no signiﬁcant dif-
ference between both groups. (P= 0.542).The weight of pa-
tients of group I ranged from 54 to 110 kg with a mean of
76.6 ± 14.9 kg and ranged from 57 to 109 kg with a mean
of 82.1 ± 16.2 kg in group II with no signiﬁcant difference be-
tween both groups (P= 0.136) Table 1.
Type of operation
Fig. 1; In Group I: Lobectomy was done in 10 patients (50%),
segmentectomy in 5 patients (25%), and lung biopsy in 5 pa-
tients (25%). While in Group II: lobectomy was done in 11 pa-
tients (55%), segmentectomy 5 patients (25%), and lung
biopsy in 4 patients (20%), with no signiﬁcant difference be-
tween both groups. (P= 0.924).
Hemodynamic data
(A) Heart rate; Fig. 2; The mean value of the level of the
heart rate in Group I was 73.5 ± 6.5 beats/min,
and74.1 ± 6.4 beats/min in Group II, with no signiﬁ-
cant difference between both groups as regards the heart
rate at the base level or at any interval of measurements
intraoperatively.
(B) Mean arterial blood pressure (MAP) mmHg: Fig. 3. The
mean value of the base level of the MAP in group I was
91.8 ± 9.6 mmHg, with no statistically signiﬁcantdifference in the MAP in relation to the preoperative
base level during the whole intraoperative intervals of
measurements. The mean value of the base level of the
MAP in group II was 93.8 ± 9.6 mmHg, with no statis-
tically signiﬁcant difference in the MAP in relation to
the preoperative base level during the whole intraopera-
tive interval of measurements. There was no signiﬁcant
difference between both groups as regards the MAP at
the base level or at any interval of measurements
intraoperative.
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Figure 2 Comparison between the two studied groups regarding changes in heart rate (beats/min).
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Figure 3 Comparison between the two studied groups regarding changes in MAP (mmHg).
736 S.A. Hammouda et al.Arterial blood gases (ABG) analysispH: There was no statistically signiﬁcant difference between
the two groups before and after OLV with a P value of
(0.780 and 0.739) respectively Table 2.PaO2 (mmHg): There was no statistically signiﬁcant differ-
ence between the two groups before and after OLV (P= 0.235
and 0.086 respectively)
PaCO2 (mmHg): There was no statistically signiﬁcant dif-
ference between the two groups as regards mean PaCO2 level
before and after OLV. (P= 0.057 and 0.067 respectively).
Table 2 Comparison between the two studied groups regarding arterial blood gases (ABG) analysis.
pH before
OLV
pH 15 min
after OLV
PaO2 before
OLV
PaO2 15 min
after OLV
PaCo2 Before OLV PaCo2 15 min
after OLV
HCO3 Before OLV HCO3 15 min
after OLV
Group I
Min 7.35 7.36 193.0 132.0 35.0 33.0 25.20 25.30
Max 7.47 7.47 387.0 234.0 45.0 45.0 29.30 29.40
Mean 7.41 7.40 271.90 184.0 38.7 38.0 26.85 27.01
±SD 0.03 0.03 56.11 28.64 2.6 2.8 1.27 1.27
Group II
Min 7.33 7.35 179.0 100.0 33.2 33.0 24.60 24.60
Max 7.47 7.45 327.0 225.0 43.0 43.0 29.10 29.10
Mean 7.41 7.40 252.25 164.20 36.8 36.3 26.74 26.53
±SD 0.04 0.03 50.82 42.57 2.6 2.6 1.35 1.36
P 0.780 0.739 0.253 0.086 0.057 0.067 0.792 0.252
P is signiﬁcant if 60.05.
Table 3 BAL and Serum analysis for IL-6 (Pg/dl) and TNF-a (Pg/dl) in group I.
Case
No.
BAL analysis Serum analysis
IL-6 (Pg/dl) TNF-a (Pg/dl) IL-6 (Pg/dl) TNF-a (Pg/dl)
Before
OLV
15 min after
OLV ended
Before
OLV
15 min after
OLV ended
Before
OLV
15 min after
OLV ended
Before
OLV
15 min after
OLV ended
1 6 17 5.2 22.8 6 15.8 10 80.5
2 8 78 6 22.1 7 16.3 12.9 66.7
3 15 80 5.1 23.6 10 26.7 12.5 60
4 10 55 6.1 25.1 6.5 25.8 16.1 77.2
5 15 16 5.3 28.7 7.9 22.4 14.1 70.3
6 12 22 6.7 31 8.2 16.6 15.1 66.9
7 31 55 6 30.1 8.9 18.4 18.9 80.6
8 28 60 6.5 27.2 9.1 36.7 19.2 88.9
9 14 20 4 20.2 9.3 17.2 11.3 66.3
10 34 84 4.5 26.8 7.2 18.9 10.1 70.4
11 35 100 6.4 25.7 8.9 28.5 10.2 80.5
12 7 10 4.9 22.7 8.5 32.4 15.3 84.6
13 30 70 7 35 9.1 30.8 14.3 77.3
14 25 57 4 23.4 10 33.9 12.5 78.3
15 22 50.6 7 34 9.9 40 20 100
16 32 60.4 7 30 8.4 40 19.9 99.5
17 6 15 5 20 7.6 20.7 14.2 85.2
18 11 60.5 6 25 7.1 38 14.3 74.6
19 18 27 4 22 9.2 16.8 12.3 66.8
20 9.3 35 5.2 23 8.6 15.2 13.7 70.7
Min 6.0 10.0 4.0 20.0 6.0 15.2 10.0 60.0
Max 35.0 100.0 7.0 35.0 10.0 40.0 20.0 100.0
Mean 18.4 48.6 5.6 25.9 8.4 25.6 14.3 77.3
±SD 10.2 26.8 1.0 4.3 1.2 8.9 3.2 10.7
P 0.0001* 0.0002* 0.0001* 0.0003*
* P is signiﬁcant if 60.05.
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ence between the two groups as regards mean HCO3 level be-
fore and after OLV (P = 0.792 and 0.252, respectively).
The pulmonary inﬂammatory response (TNF-a and IL-6)
through BAL analysis
(A) Interleukin 6 [IL-6]: Tables 3–6. In Group I; Table 3 The level of IL-6 before OLV ranged
from 6 to 35 pg/ml with a mean value of 18.4 ± 10.2 pg/
ml and after OLV ranged from 10 to 100 pg/ml with a mean
value of 48.6 ± 26.8 pg/ml with statistically signiﬁcant
increase in relation to before OLV and a P value of
(0.0001).
 In Group II :Table 4, The level of IL-6 before OLV ranged
from 4 to 40 pg/ml with a mean value of 20.6 ± 11.7 pg/ml
Table 4 BAL and Serum analysis for IL-6 (Pg/dl) and TNF-a (Pg/dl) in group II.
Case
No.
BAL analysis Serum analysis
IL-6 (Pg/dl) TNF-a (Pg/dl) IL-6 (Pg/dl) TNF-a (Pg/dl)
Before
OLV
15 min after
OLV ended
Before
OLV
15 min after
OLV ended
Before
OLV
15 min after
OLV ended
Before
OLV
15 min after
OLV ended
1 4 28.2 4.9 11.1 6 17.5 10.5 39.8
2 17.2 6.9 6 10 9 18.2 7 44.3
3 18.6 6 5.3 10.8 9.2 17 11.7 50.7
4 8.5 25.4 4.6 11.3 7.1 19.9 12.2 35
5 28.4 19.5 6.2 12.1 7.9 18.7 14.3 47.8
6 31.4 15.8 5.4 15.8 10.1 20.1 20.1 45.3
7 38.1 39.7 7.7 16.4 9 22.7 14.3 40.9
8 25.7 40.7 7.5 18.3 10.2 23.5 8.9 58.3
9 22 55.8 5.1 14.6 8 20.5 18.6 70
10 19.2 60.4 4.8 18.4 7.2 19.2 15.1 62.4
11 18.7 23.3 5.4 22.6 8.1 17.3 11.5 65.8
12 10.6 17.8 6.7 20.8 9.8 19.6 9.7 55.4
13 30.4 22.5 3.8 21.8 9.1 18.8 8.9 41.3
14 20.5 15.6 4.2 20.3 10 20.1 15.4 37.8
15 40 70 8 25 10 25 22 70
16 39.8 65.8 7.4 24.7 8.2 22.5 20.4 69.6
17 4.8 18.4 3.8 12.5 8.4 18.2 14.2 40.1
18 22.5 48.9 4.7 11.6 8.9 17.9 10.1 39.5
19 5 15.8 3.5 18.5 10.1 18.6 8.9 47.5
20 6.4 20.5 5.1 22.1 10 21.2 14.2 60.4
Min 4.0 6.0 3.5 10.0 6.0 17.0 7.0 35.0
Max 40.0 70.0 8.0 25.0 10.2 25.0 22.0 70.0
Mean 20.6 30.9 5.5 16.9 8.8 19.8 13.4 51.1
±SD 11.7 19.7 1.4 5.0 1.2 2.2 4.3 11.9
P 0.024* 0.021* 0.001* 0.002*
* P is signiﬁcant if 60.05.
Table 5 Comparison between the two studied groups regarding changes in IL-6 (Pg/dl) and TNF-a (Pg/dl) in BAL and serum.
Groups BAL analysis Serum analysis
IL-6 (Pg/dl) TNF-a (Pg/dl)
Before
OLV
15 min
after OLV
ended
Before
OLV
15 min after
OLV ended
Before
OLV
15 min
after OLV
ended
Before OLV 15 min
after OLV ended
Group I
Min 6.0 10.0 4.0 20.0 6.0 15.2 10.0 60.0
Max 35.0 100.0 7.0 35.0 10.0 40.0 20.0 100.0
Mean 18.4 48.6 5.6 25.9 8.4 25.6 14.3 77.3
±SD 10.2 26.8 1.0 4.3 1.2 8.9 3.2 10.7
Group II
Min 4.0 6.0 3.5 10.0 6.0 17.0 7.0 35.0
Max 40.0 70.0 8.0 25.0 10.2 25.0 22.0 70.0
Mean 20.6 30.9 5.5 16.9 8.8 19.8 13.4 51.1
±SD 11.7 19.7 1.4 5.0 1.2 2.2 4.3 11.9
P 0.665 0.002* 0.617 0.048* 0.208 0.038* 0.357 0.001*
* P is signiﬁcant if 60.05.
738 S.A. Hammouda et al.and after OLV ranged from 6 to 70 pg/ml with a mean value
of 30.9 ± 19.7 pg/ml with statistically signiﬁcant increase in
relation to before OLV and a P value of (0.024).
Comparing the two groups: Table 5, There was no statisti-
cally signiﬁcant difference between the two groups before OLV(P= 0.665). After OLV the level of interleukin-6 increased
signiﬁcantly in Group I in relation to Group II (P= 0.002).
B-Tumor necrosis factor a [TNF-a]: Tables 3–6.
 In Group I: Table 3; The level of TNF-a before OLV ran-
ged from 4 to 7 pg/ml with a mean value of 5.6 ± 1.0 pg/ml
Table 6 Correlation between BAL and serum levels of IL-6 and TNF-a after OLV.
Group Item IL6 TNF-a
Serum level (pg/ml) Serum level (pg/ml)
r P r P
Group I BAL 15 min after OLV ended (pg/ml) 0.28 0.231 0.31 0.184
Group II BAL 15 min after OLV ended (pg/ml) 0.45 0.041* 0.54 0.014*
r: Spearman correlation co efﬁcient.
* P is signiﬁcant if 60.05.
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value of 25.9 ± 4.3 pg/ml with statistically signiﬁcant
increase in relation to before OLV and a P value of
(0.0002).
 In Group II: Table 4; The level of TNF-a before OLV ran-
ged from 3.5 to 8 pg/ml with a mean value of 5.5 ± 1.4 pg/
ml and after OLV ranged from 10 to 25 pg/ml with a mean
value of 19.6 ± 5.0 pg/ml with statistically signiﬁcant
increase in relation to before OLV and a P value of (0.021).
Comparing the two groups: Table 5; There was no statisti-
cally signiﬁcant difference between the two groups before OLV
(P= 0.617). After OLV level of TNF-a increased signiﬁcantly
in Group I in relation to Group II (P= 0.048).
The systemic inﬂammatory response (TNF-a and IL-6) through
serum analysis
A- Interleukin 6 [IL-6]; Tables 3–6.
 In Group I: Table 3: The level of IL-6 before OLV ranged
from 6 to 10 pg/ml with a mean value of 8.4 ± 1.2 pg/ml
and after OLV ranged from 15.2 to 40 pg/ml with a mean
value of 25.6 ± 9.8 pg/ml with statistically signiﬁcant
increase in relation to before OLV and a P value of
(0.0001).
 In Group II: Table 4: The level of IL-6 before OLV ranged
from 6 to 10.2 pg/ml with a mean value of 8.8 ± 1.2 pg/ml
and after OLV ranged from 17 to 25 pg/ml with a mean
value of 19.8 ± 2.2 pg/ml with statistically signiﬁcant
increase in relation to before OLV and a P value of (0.001).
Comparing the two groups: Table 5; There was no statisti-
cally signiﬁcant difference between the two groups before
OLV (P= 0.208). After OLV level of interleukin-6 increased
signiﬁcantly in Group I in relation to Group II (P= 0.038).
B-Tumor necrosis factor a [TNF-a], Tables 3–6.
 In Group I: Table 3; The level of TNF-a before OLV ranged
from 10 to 20 pg/ml with a mean value of 14.3 ± 3.2 pg/ml
and after OLV ranged from 60 to 100 pg/ml with a mean
value of 77.3 ± 10.7 pg/ml with statistically signiﬁcant
increase in relation to before OLV and a P value of
(0.0003).
 In Group II: Table 4; The level of TNF-a before OLV
ranged from 7 to 22 pg/ml with a mean value of
13.4 ± 4.3 pg/ml and after OLV ranged from 35 to 70 pg/
ml with a mean value of 51.1 ± 11.9 pg/ml with statistically
signiﬁcant increase in relation to before OLV and a P value
of (0.002)Comparing the two groups: Table 5; There was no statisti-
cally signiﬁcant difference between the two groups before
OLV (P= 0.375). After OLV level of TNF-a increased signif-
icantly in Group I in relation to Group II (P= 0.001). A sig-
niﬁcant correlation (Table 6) was present between increased
level of IL-6 and TNF-a in serum and their increase in BAL
after OLV in group II but this correlation was not present in
group I.
C-reactive protein (CRP) in serum: Fig. 4.
 In Group I: Fig. 5; The level of CRP before OLV ranged
from 2.5 to 6.5 pg/ml with a mean value of 4.1 ± 1.1 pg/
ml, after OLV it ranged from 6.9 to 27 pg/ml with a mean
value of 15.8 ± 5.4 pg/ml and on the 2nd postoperative
day it ranged from 9.6 to 41 pg/ml with a mean value of
23.8 ± 7.7 pg/ml. There was signiﬁcant increase in the level
of CRP after OLV and on the 2nd postoperative day rela-
tive to level before OLV with a P value of (0.0001 and
0.0002) respectively.
 In Group II: Fig. 6; The level of CRP before OLV ranged
from 2.5 to 5.8 pg/ml with a mean value of 4.1 ± 1.1 pg/
ml, after OLV it ranged from 5.6 to 25.9.
Pg/ml with a mean value of 12.5 ± 5.8 pg/ml and on the
2nd postoperative day it ranged from 8.6 to 39.9 pg/ml with
a mean value of 19.4 ± 7.8 pg/ml. There was signiﬁcant in-
crease in the level of CRP after OLV and on the 2nd postop-
erative day relative to the level before OLV with a P value
of (0.002 and 0.003) respectively.
Comparing the two groups: Fig. 6; There was no statistically
signiﬁcant difference between the two groups before OLV
(P= 0.184).After OLV and on the 2nd postoperative day
the level of CRP increased signiﬁcantly in Group I relative
to Group II (P= 0.040 and 0.036) respectively.
Leukocyte count (WBC) (·103): Fig. 5.
 In Group I: Fig. 5; The level of WBC before OLV ranged
from 4.5to 8.9 with a mean value of 6.6 ± 1.3, after OLV
it ranged from 5.5 to 9.3 with a mean value of
7.49 ± 0.90 and on the 2nd postoperative day it ranged
from 7.5 to 12 with a mean value of 9.78 ± 1.19. There
was signiﬁcant increase in the level of WBC after OLV
and on the 2nd postoperative day relative to the level before
OLV with a P value of (0.012 and 0.001), respectively.
 In Group II: Fig. 5; The level of WBC before OLV ranged
from 5 to 9.5 with a mean value of 6.8 ± 1.3, after OLV it
ranged from 5.2 to 11 with a mean value of 7.5 ± 1.4 and
on the 2nd postoperative day it ranged from 6.8 to 11.8 with
a mean value of 8.8 ± 1.5. There was no signiﬁcant increase
in the level of WBC after OLV and a signiﬁcant increase in
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740 S.A. Hammouda et al.the level of WBC on the 2nd postoperative day relative to
the level before OLV with a P value of (0.089 and 0.002)
respectively.
Comparing the two groups: Fig. 5; There was no statistically
signiﬁcant difference between the two groups before OLV and
after OLV with a P value of (0.578 and 0.893) respectively. On
the 2nd postoperative day the level of WBC increased signiﬁ-
cantly in Group I relative to Group II (P= 0.015).
Duration of anesthesia, surgery and OLV (mins): Duration
of anaesthesia In group I it ranged from 97 to 202 min with a
mean of 150.95 ± 36.76 min and ranged from 97 to 207 min
with a mean of 146 ± 35.94 min in group II with no signiﬁcant
difference between both groups (P= 0.669).
Duration of surgery; In group I it ranged from 75 to
180 min with a mean of 131.25 ± 36.05 min and ranged from
75 to 180 min with a mean of 123.75 ± 35.72 min in group II
with no signiﬁcant difference between both groups
(P= 0.513).
Duration of OLV; In group I it ranged from 38 to 135 min
with a mean of 88.9 ± 32.16 min and ranged from 44 to
130 min with a mean of 83.2 ± 30.61 min in group II with
no signiﬁcant difference between both groups (P= 0.569).There was no signiﬁcant correlation between duration of
OLV with inﬂammatory mediators (IL-6 and TNF-a) in serum
and BAL Table 7. Also no signiﬁcant correlation between
duration of OLV with the increased levels of CRP and WBC
count in both groups (Table 8).
Recovery status (modiﬁed Steward Score); Fig. 6
On Admission to the recovery room
Consciousness; There was no statistically signiﬁcant difference
between the two groups with a P value of (0.530).
Airway patency; There was no statistically signiﬁcant dif-
ference between the two groups with a P value of (0.317).
Motor activity; There was no statistically signiﬁcant differ-
ence between the two groups with a P value of (0.202).
Fifteen minutes thereafter
Consciousness; There was no statistically signiﬁcant difference
between the two groups with a P value of (0.965).
Airway patency; There was no statistically signiﬁcant dif-
ference between the two groups with a P value (0298).
Motor activity; There was no statistically signiﬁcant differ-
ence between the two groups with a P value of (0.987).
Comparing the two groups on admission to recovery room
and 15 min thereafter: Fig. 6, there was signiﬁcant increase in
total score 15 min after admission to recovery room relative
to time of admission in both group I and group II with a P va-
lue of (0.001 and 0.003) respectively.
Discussion
The present study was carried out on 40 adult patients of both
sex admitted to the cardiothoracic surgery department of the
Alexandria Main University Hospital, scheduled for elective
lung resection surgery through thoracotomy under general
anesthesia. Patients were randomly classiﬁed using closed
envelope technique into two equal groups. In group I patients
received total intravenous anesthesia with propofol and in
group II patients received inhalational anesthesia with
sevoﬂurane.
Table 7 Correlation between BAL and serum levels of IL-6 and TNF-a after OLV with OLV duration.
Group Item BAL Serum
OLV duration OLV duration
r P r P
Group I TNF-a after OLV (pg/ml) 0.05 0.838 0.21 0.367
IL6 after OLV (pg/ml) 0.34 0.138 0.05 0.843
Group II TNF-a after OLV (pg/ml) 0.09 0.719 0.35 0.128
IL6 after OLV (pg/ml) 0.21 0.364 0.01 0.990
r: Spearman correlation co efﬁcient.
P is signiﬁcant if 60.05.
Table 8 Correlation between CRP level and WBC count on
2nd postoperative day with duration of OLV.
Group Item OLV duration
r P
Group I WBCs 2nd postoperative day 0.09 0.707
CRP 2nd postoperative day 0.05 0.835
Group II WBCs 2nd postoperative day 0.04 0.858
CRP 2nd postoperative day 0.35 0.136
r: Spearman correlation coefﬁcient.
P is signiﬁcant if 60.05.
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signiﬁcant difference between the two studied groups as re-
gards age, sex, and height and body weight.
As regards type of operation there was no statistically sig-
niﬁcant difference between the two studied groups.
In the present study, the basal readings of heart rate and
MAP were within normal physiological ranges with no signif-
icant difference between both groups during all times of
measurements.
In the current study there was no signiﬁcant difference in
ABG analysis between both groups. Also in each group there
was no signiﬁcant difference in ABG analysis after OLV rela-
tive to before OLV except for PaO2 where it was signiﬁcantly
decreased after OLV in both groups.
In agreement with the present study Pruszkowski et al. [13]
found that no signiﬁcant difference between sevoﬂurane and
propofol on Pao2 before and during OLV, the choice between
these anesthetic agents could be independent of their effects on
oxygenation. Also there was signiﬁcant decrease in PaO2 in
both groups during OLV.
In a study done by Karzai et al. [14] they compared the ef-
fects of desﬂurane with those of propofol on oxygenation dur-
ing TLV and OLV.They found that when changing from TLV
to OLV, PaO2 decreased more during desﬂurane than during
propofol. Changing between desﬂurane and propofol during
OLV resulted in small but signiﬁcant increases in PaO2 during
propofol.
In the present study, there was no statistically signiﬁcant
difference between both groups regarding the base level (before
OLV) of interleukin-6 and TNF-a in BAL and serum with sta-
tistically signiﬁcant increase in both groups after OLV but
more increase in group I relative to group II. No signiﬁcant
correlation between the duration of OLV and increased levels
of IL-6 and TNF-a in BAL and serum was present in bothgroups. A signiﬁcant correlation was present between in-
creased level of IL-6 and TNF-a in serum and their levels in
BAL after OLV in the group II but this correlation was not
present in groupI.
In agreement with the present study De Conno et al. [15]
compared the effect of propofol versus sevoﬂurane on both
pulmonary and systemic inﬂammatory response in thoracic
surgery through BAL and serum analysis for inﬂammatory
mediators. Inﬂammatory mediators (tumor necrosis factor –
a, interleukin 1B, interleukin 6, interleukin 8, monocyte che-
moattractant protein 1) were analyzed in BAL and serum.
They found that OLV resulted in an increase in the measured
inﬂammatory mediators in both groups. However, the increase
of inﬂammatory mediators upon OLV in porpofol group was
signiﬁcantly higher for all parameters except IL-1B compared
with sevoﬂurane group.
In another study Sugasawa et al. [16] compared the pul-
monary and systemic inﬂammatory effects of sevoﬂurane with
propofol and investigated whether the pulmonary immuno-
modulatory effects might differ in the dependent lung and
the nondependent lung during thoracic surgery. Epithelial lin-
ing ﬂuid (ELF) was obtained from each lung using a broncho-
scopic microsampling method. ELF and plasma levels of
inﬂammatory cytokines were measured before and after
OLV. They found that ELF levels of interleukin (IL)-1B, IL-
6, and IL-8 were signiﬁcantly increased in the dependent and
the nondependent lung after OLV compared with baseline lev-
els in both groups. Moreover, IL-6 ELF level in the dependent
lung was signiﬁcantly higher in the propofol group than in the
sevoﬂurane group after OLV. Serum cytokine concentrations
observed in their study were not accompanied by the alveolar
proinﬂammatory response because the plasma cytokine levels
of TNF-a, IL-1B, IL-6, IL-8, IL-10, and IL-12p70 were unde-
tectable in both groups.
During thoracic surgery, Mahmoud et al. [17] compared the
effects of propofol versus isoﬂurane on alveolar and plasma
concentrations of interleukin-8(IL-8) and tumour necrosis fac-
tor-a (TNF-a) malondialdehyde (MDA), superoxide dismutase
(SOD), and changes in alveolar albumin concentrations and
cell numbers. MDA is an indicator of lipid peroxidation,
whereas SOD is an antioxidant enzyme that helps in scaveng-
ing free radicals which play a role in tissue injury. Bronchoal-
veolar lavage of the ventilated dependant lung was done at
three time points, after induction of anaesthesia (before
OLV), one hour after OLV and one hour after surgery. They
found that one hour after OLV and one hour after surgery
the alveolar concentration of IL-8 and TNF-a were signiﬁ-
cantly lower in the isoﬂurane group, where as alveolar concen-
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Alveolar SOD level increased signiﬁcantly in the propofol
group whereas it showed no signiﬁcant change in the isoﬂurane
group. Furthermore, the isoﬂurane group patients developed
signiﬁcantly lower alveolar albumin concentrations and cell
numbers. The plasma concentrations of IL-8, TNF-a increased
signiﬁcantly in both groups after OLV, however, they were sig-
niﬁcantly lower in the isoﬂurane group.
According to CRP level, it was signiﬁcantly increased after
OLV and on the 2nd postoperative day in both groups and it
was signiﬁcantly increased in group I relative to group II.
The level of WBC was signiﬁcantly increased in group I
after OLV and on the 2nd postoperative day however it was
signiﬁcantly increased in group II on the 2nd postoperative
day without signiﬁcant change after OLV. Comparing the
two groups the WBC level was signiﬁcantly increased in group
I relative to group II on the 2nd postoperative day without sig-
niﬁcant change after OLV.
De Conno et al. [15] assessed C-reactive protein and blood
leukocyte count as additional parameters for inﬂammation
preoperatively, on ﬁrst postoperative day(POD1),third postop-
erative day (POD3), and ﬁfth postoperative day (POD5) to
determine possible differences in the sevoﬂurane compared
with the propofol group. They found that there was no statis-
tically signiﬁcant difference in CRP and leukocyte count could
be detected between the two groups from POD1 to POD5.
However there was signiﬁcant increase in CRP and WBC levels
in both groups from POD1 to POD5 with a signiﬁcant corre-
lation between CRP values and OLV time on POD1 in the pro-
pofol group only. A correlation was observed between CRP
value on POD1 and increase of plasma IL-6 and MCP-1 con-
centration in the propofol group, whereas no correlation was
observed in the sevoﬂurane group as a result of the signiﬁcant
difference in OLV time between the two groups (longer dura-
tion of OLV in the propofol group (140 ± 76 min) versus the
sevoﬂurane group (98 ± 57 min).
As regarding duration of anaesthesia, surgery and OLV,
there was no statistically signiﬁcant difference between the two
studied groups with no signiﬁcant correlation between duration
of OLV and inﬂammatory mediators in serum and BAL. Also
no signiﬁcant correlation between duration of OLV with the in-
creased levels of CRP and WBC count in both groups.
In agreement with the current study Leite et al. [18] found
that the experimental mechanical ventilation in rats with a pro-
longed surgical time did not produce signiﬁcant local and sys-
temic inﬂammatory changes and permit to evaluate other
procedures in thoracic surgery.
In contrast with the current study.
In the study of Sugasawa et al. [16] the magnitude of cyto-
kine expression in ELF after OLV showed a progressive in-
crease with prolonged duration of OLV in both groups.
There was a correlation between the increase in the level of
IL-1b, IL-6, or IL-8 and the duration of OLV in the dependent
and the nondependent lung after OLV. Also De Conno et al.
[15] found a progressive increase in TNF-a, IL-6, IL-8,
MCP-1, and to a lesser degree IL-1B was observed with
increasing duration of OLV.
Regarding recovery proﬁle there was no signiﬁcant differ-
ence between both groups regarding to consciousness level, air-
way patency and motor activity on admission to recoveryroom and 15 min after that, however there was signiﬁcant in-
crease in total recovery score 15 min after admission to recov-
ery room in both studied groups without signiﬁcant difference
in between.
Considering the data from other studies in combination
with the results of the present study OLV increased the concen-
tration of alveolar macrophages and granulocytes proteins,
and inﬂammatory cytokines [15]. IL-6 is an important che-
mo-attractant that affects the recruitment of granulocytes
and alveolar macrophages [19]. Alveolar macrophages not
only act as phagocytes but also secrete biologically active
products, thereby playing a signiﬁcant role in regulating pul-
monary inﬂammatory reactions [20]. Evidence was mounted
to suggest that increased levels of these inﬂammatory cytokines
could be clinically relevant to pulmonary complications fol-
lowing thoracic surgery with a potential link between inﬂam-
matory mediators in the lung and outcome [15] OLV in
patients undergoing lung resection promotes the production
and release of proinﬂammatory substances in the alveoli.
Moreover, the administration of sevoﬂurane signiﬁcantly sup-
presses pulmonary proinﬂammatory response to a greater ex-
tent than propofol and so improved outcome for patients in
the sevoﬂurane group. These observations were likely to be re-
lated to the more enhanced immunomodulatory effect of sevo-
ﬂurane. The underlying mechanism for this type of
immunomodulation is thought to involve interaction with
inducible nitric oxide synthetase by reversible inhibition of
voltage-dependent calcium channels and subsequent reduc-
tions in intracellular calcium concentration [21].
Conclusion
 The mechanical ventilation and the surgical manipulation
induced alveolar and systemic inﬂammatory responses in
patients who had undergone lung resection.
 Pulmonary and systemic inﬂammatory reactions as
reﬂected by the level of IL-6 and TNF-a are affected by
OLV and anesthetic agents.
 After OLV, both propofol and sevoﬂurane increased the
release of pulmonary and systemic inﬂammatory mediators
namely IL-6 and TNF-a.
 Propofol increased pulmonary and systemic cytokine
release more than sevoﬂurane during OLV.
 A signiﬁcant correlation was present between increased
level of IL-6 and TNF-a in BAL and their levels in serum
after OLV in the group II but this correlation was not pres-
ent in the groupI.
 The administration of both propofol and sevoﬂurane
increased release of CRP level and WBC count after OLV
and on 2nd postoperative day.
 Propofol has increased CRP level and WBC count more
than sevoﬂurane during OLV.Recommendations
 Administration of sevoﬂurane anesthesia is recommended
during lung resection in patients undergoing open thoracic
surgery using OLV technique.
Immunomodulatory effect of propofol versus sevoﬂurane in patients undergoing thoracic surgery 743 Further studies are needed to study other anesthetic tech-
niques that can be used to decrease the inﬂammatory
response during lung resection.
 Further studies are needed to study the immunomodulatory
effects of other anaesthetics during OLV in thoracotomy.
 Further studies are needed to study the immunomodulatory
effects of propofol and sevoﬂurane during OLV in other
thoracic surgeries as telescopic and esophageal surgeries.
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